The SMA treatment program is complete, in line with standards. Patients have access to all registered therapies, Deputy Health Minister Marek Kos told the Sejm on Thursday. Outlays for the program are increasing, he reported. This year, PLN 475 million has already been spent, while in the entire...
Phil Krzyzek was elected president of INFARMA's Board of Directors in December 2024. The election of the new CEO follows the resignation of Agnieszka Grzybowska-Zalewska, who had held the position since June 2023.
The next meeting of the Transparency Council will be held on Monday, December 23.
4,500 price negotiations and 54 meetings resulted - it was a busy year for the Economic Commission. 86% of reimbursement requests resulted in a price agreement at the Commission level.In addition, a dedicated website for EC activities was created in 2024, where minutes of divergence, meeting...
It was an important year for building foundations of Poland's drug security. In 2024. statutory incentives to increase the production of medicines in the country took effect, and after several years of discussions, the government prepared a list of medicines critical to the health and life of...
On Monday, December 16, the next meeting of the Transparency Council.
On Monday, December 9, the next meeting of the Transparency Council.
The Ministry of Health has announced that HPV DNA diagnostics is expected to become a diagnostic standard in Poland from January 2025. Pilot studies of the use of the HPV HR molecular test have already been completed in 2022, and AOTMiT has also issued a positive opinion, but despite this, the...
The Health Ministry has published the Draft Announcement of the Minister of Health on the list of reimbursed drugs, foodstuffs for special nutritional purposes and medical devices, which will come into effect on January 1, 2025.
Urologists from the Świętokrzyskie Oncology Center have performed the first percutaneous cryoablation of kidney tumors in patients with cancer of this organ in the Świętokrzyskie region. There are only a few centers in Poland performing such procedures.
At the end of July, Atellas, the manufacturer of the drug Asamax, confirmed that it was ending production of the drug. The agent will not be reimbursed from the new year. This has caused concern among patients with inflammatory bowel disease for whom the drug is used. - There is no need to sow...
This is a very important step toward building our security, and it is worth appreciating that the health ministry has done this work," says Krzysztof Kopeć, president of the National Drug Manufacturers.
Endometriosis, lung cancer and breast cancer are just examples of diseases that are difficult to detect, and the comfort and sometimes the life of the patient may depend on their diagnosis. Scientists at the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences can help speed...
On Monday, December 2, the next meeting of the Transparency Council.
The MojeIKP mobile application, developed by the e-Health Center, won in the Digital Strategic Perspective category of this year's Digital Excellence Awards.
The Supreme Audit Institution's report for 2019-2023 indicates irregularities in the process of granting OTC categories, supervision of drug quality and distribution, and handling of reports of adverse drug reactions.
The country's drug manufacturers are calling for pharmaceutical manufacturers and distributors to be protected from restrictions on electricity consumption and supply. They stress that even a short-lived interruption of electricity supplies to pharmaceutical plants risks several days of...
The next meeting of the Transparency Council will be held on Monday, November 25.
The Ministry of Health has published a new list of drugs and medical devices at risk of unavailability on Polish territory. These drugs must not be exported abroad. Which preparations and medical devices are missing?
On Monday, November 18, the next meeting of the Transparency Council.
The Świętokrzyskie Oncology Center has implemented state-of-the-art solutions to implement new radiotherapy treatment techniques and precise monitoring of the irradiation area. It is the first in Poland to use a system that increases the precision of patient positioning during treatment with a...
Polish data demonstrate the clinical utility of the Oncotype DX® test in making chemotherapy decisions for patients with early-stage breast cancer. Real-world data from more than 200 patients show the test's impact on treatment decisions, reducing potential over- and under-treatment with...
The President of the Republic of Poland, Andrzej Duda, handed out nomination acts to academic teachers and employees of science and the arts. Nineteen professorial appointments were given to health-related individuals.
On November 12, the next meeting of the AOTMiT Transparency Council?
The Agency for Medical Research (ABM) has announced the outcome of the Open Competition for non-commercial clinical trials and research experiments (ABM/2024/1). As a result of the competition, which ran from March to May 2024, funding with a total value of more than PLN 278 million was awarded...
In the hybrid room of the Hemodynamics and Angiography Laboratory (Clinical Department of Interventional Cardiology with Intensive Cardiac Care Unit) at the St. John Paul II Specialized Hospital in Krakow, the first successful in Europe and the second in the world innovative procedure of...
A team of researchers from the National Cancer Institute in Gliwice, in collaboration with the Silesian Medical University in Katowice and the Institute of Cancer Research in London, has developed a novel immuno-PET imaging technique using a Zr-89-labeled antibody that could enable patients with...
- We are aiming to be able to talk about evidence-based apitherapy. The idea is that apitherapy should be based on specific scientific studies and on relevant standards," says Miroslaw Szczepanski, MD, PhD, from the Medical University of Warsaw, a specialist in laryngology and president of the...
On Monday, November 4, the next meeting of the Transparency Council.
Biogen publishes new data on the efficacy and safety of a higher dose of nusinersen.
© 2023 Medexpress. All Rights Reserved
